Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor
Hormone Research in Paediatrics, 08/17/2012
Simmons JH et al. – Exenatide resulted in considerable reduction of body weight in a patient with severe hypothalamic obesity. This novel observation requires follow–up clinical studies for establishing the effects of exenatide in patients with disrupted hypothalamic energy regulatory pathways.